自身免疫性神经炎症中的调节性T细胞。
Regulatory T cells in autoimmune neuroinflammation.
作者信息
Kleinewietfeld Markus, Hafler David A
机构信息
Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Faculty of Medicine, Dresden University of Technology (TUD), Dresden, Germany.
出版信息
Immunol Rev. 2014 May;259(1):231-44. doi: 10.1111/imr.12169.
Abstract
Regulatory T cells are the central element for the maintenance of peripheral tolerance. Several subtypes of regulatory T (Treg) cells have been described, and most of them belong to the CD4(+) T-helper (Th) cell lineage. These specific subtypes can be discriminated according to phenotype and function. Forkhead box protein 3 (FoxP3)-expressing natural Treg cells (Tregs) and IL-10-producing, T-regulatory type 1 cells (Tr1) are the best-studied types of CD4(+) regulatory T cells in humans and experimental animal models. It was shown that they play a crucial role during autoimmune neuroinflammation. Both cells types seem to be particularly important for multiple sclerosis (MS). Here, we discuss the role of CD4(+) regulatory T cells in autoimmune neuroinflammation with an emphasis on Tregs and Tr1 cells in MS.
摘要
调节性T细胞是维持外周免疫耐受的核心要素。已描述了几种调节性T（Treg）细胞亚型，其中大多数属于CD4(+)辅助性T（Th）细胞谱系。这些特定亚型可根据表型和功能进行区分。表达叉头框蛋白3（FoxP3）的天然Treg细胞（Tregs）和产生白细胞介素-10的1型调节性T细胞（Tr1）是在人类和实验动物模型中研究得最为深入的CD4(+)调节性T细胞类型。研究表明，它们在自身免疫性神经炎症过程中发挥着关键作用。这两种细胞类型似乎对多发性硬化症（MS）尤为重要。在此，我们讨论CD4(+)调节性T细胞在自身免疫性神经炎症中的作用，重点关注MS中的Tregs和Tr1细胞。
相似文献
1
Regulatory T cells in autoimmune neuroinflammation.自身免疫性神经炎症中的调节性T细胞。
Immunol Rev. 2014 May;259(1):231-44. doi: 10.1111/imr.12169.
2
Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.在食蟹猴模拟人类多发性硬化症的模型中，IL-10 产生的 1 型调节性 T 细胞和 CD4(+)CD25(+)调节性 T 细胞功能障碍。
Int Immunopharmacol. 2009 May;9(5):599-608. doi: 10.1016/j.intimp.2009.01.034. Epub 2009 Feb 10.
3
CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.CD39+Foxp3+调节性T细胞抑制致病性Th17细胞，且在多发性硬化症中功能受损。
J Immunol. 2009 Dec 1;183(11):7602-10. doi: 10.4049/jimmunol.0901881. Epub 2009 Nov 16.
4
Primaquine elicits Foxp3 regulatory T cells with a superior ability to limit CNS autoimmune inflammation.伯氨喹可诱导 Foxp3 调节性 T 细胞，具有更强的抑制中枢神经系统自身免疫炎症的能力。
J Autoimmun. 2020 Nov;114:102505. doi: 10.1016/j.jaut.2020.102505. Epub 2020 Jun 25.
5
The NF-κB transcription factor RelA is required for the tolerogenic function of Foxp3(+) regulatory T cells.NF-κB 转录因子 RelA 是 Foxp3(+)调节性 T 细胞耐受功能所必需的。
J Autoimmun. 2016 Jun;70:52-62. doi: 10.1016/j.jaut.2016.03.017. Epub 2016 Apr 7.
6
An autoimmune transcriptional circuit drives FOXP3 regulatory T cell dysfunction.自身免疫转录电路驱动 FOXP3 调节性 T 细胞功能障碍。
Sci Transl Med. 2024 Aug 28;16(762):eadp1720. doi: 10.1126/scitranslmed.adp1720.
7
AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease.AKT亚型在人类自身免疫性疾病中调节Th1样调节性T细胞的产生和功能。
EMBO Rep. 2016 Aug;17(8):1169-83. doi: 10.15252/embr.201541905. Epub 2016 Jun 16.
8
Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.调节性 T 细胞可塑性和稳定性与自身免疫性疾病。
Clin Rev Allergy Immunol. 2020 Feb;58(1):52-70. doi: 10.1007/s12016-018-8721-0.
9
Regulatory T cells in multiple sclerosis and myasthenia gravis.多发性硬化症和重症肌无力中的调节性T细胞。
J Neuroinflammation. 2017 Jun 9;14(1):117. doi: 10.1186/s12974-017-0892-8.
10
Membrane-bound Dickkopf-1 in Foxp3 regulatory T cells suppresses T-cell-mediated autoimmune colitis.Foxp3调节性T细胞中的膜结合型Dickkopf-1抑制T细胞介导的自身免疫性结肠炎。
Immunology. 2017 Oct;152(2):265-275. doi: 10.1111/imm.12766. Epub 2017 Jun 27.
引用本文的文献
1
Exploring the mycobiota in multiple sclerosis: its influence on disease development and progression.探索多发性硬化症中的真菌群落：其对疾病发展和进展的影响。
Front Immunol. 2025 Jul 23;16:1625794. doi: 10.3389/fimmu.2025.1625794. eCollection 2025.
2
Identification and analysis of pyroptosis-related key genes in heart failure.心力衰竭中细胞焦亡相关关键基因的鉴定与分析
J Cardiothorac Surg. 2025 Jul 14;20(1):300. doi: 10.1186/s13019-025-03530-7.
3
Circulating Biomarkers to Predict Post-Operative Cognitive Decline in Patients Undergoing Coronary Artery Bypass Grafting.预测冠状动脉搭桥手术患者术后认知功能下降的循环生物标志物
Cell Mol Neurobiol. 2025 Apr 21;45(1):37. doi: 10.1007/s10571-025-01553-1.
4
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME.抗血管内皮生长因子治疗通过对肿瘤微环境进行BAFF和IL-12依赖性重编程来增强免疫检查点阻断作用。
Immunity. 2025 Apr 8;58(4):926-945.e10. doi: 10.1016/j.immuni.2025.02.017. Epub 2025 Mar 14.
5
CHI3L1 in Multiple Sclerosis-From Bench to Clinic.多发性硬化症中的几丁质酶3样蛋白1——从实验台到临床
Cells. 2024 Dec 17;13(24):2086. doi: 10.3390/cells13242086.
6
Build muscles and protect myelin.增强肌肉并保护髓磷脂。
NeuroImmune Pharm Ther. 2024 Oct 16;3(3-4):175-182. doi: 10.1515/nipt-2024-0015. eCollection 2024 Sep.
7
Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations.调节性 T 细胞：免疫平衡的掌控者和未来治疗创新的源泉。
Front Immunol. 2024 Sep 3;15:1457189. doi: 10.3389/fimmu.2024.1457189. eCollection 2024.
8
Increased frequencies of highly activated regulatory T cells skewed to a T helper 1-like phenotype with reduced suppressive capacity in dengue patients.登革热患者体内高度活化的调节性 T 细胞频率增加，表现出类似于辅助性 T 细胞 1 的表型，其抑制能力降低。
mBio. 2024 Jun 12;15(6):e0006324. doi: 10.1128/mbio.00063-24. Epub 2024 May 16.
9
The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis.肠道衍生的短链脂肪酸在多发性硬化中的作用。
Neuromolecular Med. 2024 Apr 17;26(1):14. doi: 10.1007/s12017-024-08783-4.
10
Emerging T cell immunoregulatory mechanisms in multiple sclerosis and Alzheimer's disease.多发性硬化症和阿尔茨海默病中新兴的T细胞免疫调节机制。
Front Aging Neurosci. 2024 Feb 16;16:1350240. doi: 10.3389/fnagi.2024.1350240. eCollection 2024.
本文引用的文献
1
2
The plasticity of human Treg and Th17 cells and its role in autoimmunity.人类调节性 T 细胞和 Th17 细胞的可塑性及其在自身免疫中的作用。
Semin Immunol. 2013 Nov 15;25(4):305-12. doi: 10.1016/j.smim.2013.10.009. Epub 2013 Nov 5.
3
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.免疫相关基因座分析鉴定出多发性硬化症的 48 个新易感变异。
Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29.
4
IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.IL-27 通过诱导免疫调节分子 CD39 的表达作用于 DCs 抑制 T 细胞反应和自身免疫。
Nat Immunol. 2013 Oct;14(10):1054-63. doi: 10.1038/ni.2695. Epub 2013 Sep 1.
5
Peripherally induced tregs - role in immune homeostasis and autoimmunity.外周诱导的调节性 T 细胞——在免疫稳态和自身免疫中的作用。
Front Immunol. 2013 Aug 7;4:232. doi: 10.3389/fimmu.2013.00232. eCollection 2013.
6
The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies.调节性 T 细胞与效应性 T 细胞在自身免疫性肝炎中的相互作用：对创新治疗策略的影响。
J Autoimmun. 2013 Oct;46:74-80. doi: 10.1016/j.jaut.2013.06.016. Epub 2013 Jul 17.
7
Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction.系统性硬皮病患者体内 CD4(+)CD25(+)FoxP3(+)T 细胞水平升高，导致 IL-17 的分泌和免疫抑制功能障碍。
PLoS One. 2013 Jun 11;8(6):e64531. doi: 10.1371/journal.pone.0064531. Print 2013.
8
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.BACH2 抑制效应器程序以稳定 T（reg）介导的免疫动态平衡。
Nature. 2013 Jun 27;498(7455):506-10. doi: 10.1038/nature12199. Epub 2013 Jun 2.
9
Specific peripheral B cell tolerance defects in patients with multiple sclerosis.多发性硬化症患者特定的外周 B 细胞耐受缺陷。
J Clin Invest. 2013 Jun;123(6):2737-41. doi: 10.1172/JCI68775. Epub 2013 May 15.
10
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.CD49b 和 LAG-3 的共表达可鉴定人和小鼠 T 调节型 1 细胞。
Nat Med. 2013 Jun;19(6):739-46. doi: 10.1038/nm.3179. Epub 2013 Apr 28.
Zotero 插件